Red Bulb Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.30 Cr
- Company Age 8 Year, 13 Days
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 121.45%
- Profit Growth 21.89%
- Ebitda 19.28%
- Net Worth -33.13%
- Total Assets -19.10%
About Red Bulb Medical Technologies
Red Bulb Medical Technologies Private Limited (RBMTPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 February 2017 (Eight years 13 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anand Gampa and Abhijeet Dashetwar serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33309TG2017PTC115146
- Company No.
115146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Red Bulb Medical Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijeet Dashetwar  | Director | 10-Feb-2017 | Current |
| Anand Gampa | Director | 10-Feb-2017 | Current |
Financial Performance of Red Bulb Medical Technologies.
Red Bulb Medical Technologies Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 121.45% increase. The company also saw a substantial improvement in profitability, with a 21.89% increase in profit. The company's net worth observed a substantial decline by a decrease of 33.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Red Bulb Medical Technologies?
In 2019, Red Bulb Medical Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neosun Biotech (India) Private LimitedAnand Gampa is a mutual person
- Cohealth India Llp
Abhijeet Dashetwar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Red Bulb Medical Technologies?
Unlock and access historical data on people associated with Red Bulb Medical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Red Bulb Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Red Bulb Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.